Department of Obstetrics and Gynaecology, Zaans Medisch Centrum, Zaandam, the Netherlands; Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands.
Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, the Netherlands.
Fertil Steril. 2016 Jan;105(1):156-64.e1-2. doi: 10.1016/j.fertnstert.2015.09.021. Epub 2015 Oct 9.
To examine the long-term complications and reproductive outcomes after the management of retained products of conception (RPOC).
Systematic review.
Not applicable.
PATIENT(S): Women suspected of RPOC who were subjected to medical therapy with misoprostol or surgical treatment.
INTERVENTION(S): An electronic literature search was conducted in June 2015 using MEDLINE, EMBASE, and the Cochrane library. We included clinical trials in which women were consecutively included, independent of their symptoms.
MAIN OUTCOME MEASURE(S): The prevalence of intrauterine adhesions (IUAs) and reproductive outcomes.
RESULT(S): No studies reporting on IUAs or reproductive indicators after medical management with misoprostol were found. We included 10 cohort studies with poor to average methodological quality. Five cohort studies (n = 339) reported IUAs in 22.4% (95% confidence interval, 18.3%-27%) of women hysteroscopically evaluated. Significantly more IUAs were encountered after dilation and curettage (D&C) compared with after hysteroscopic resection (HR): 30% vs. 13%. Incomplete evacuation was encountered in, respectively, 29% and 1% of the D&C and HR cases. Similar conception, ongoing pregnancy, live-birth, and miscarriage rates were reported after D&C and HR in six cohort studies (n = 380), and there was a tendency toward earlier conception after HR. The reproductive outcomes were not reported in relation to IUAs.
CONCLUSION(S): HR may be a preferable surgical treatment in women suspected of RPOC; fewer IUAs and incomplete evacuations are encountered, while similar reproductive outcomes were reported compared with D&C. Confirmation of the observed effects is required, and trials evaluating medical treatment with misoprostol as well as expectant management are urgently needed.
探讨治疗妊娠物残留(RPOC)后的长期并发症和生殖结局。
系统评价。
不适用。
疑似 RPOC 的接受米索前列醇药物治疗或手术治疗的女性。
2015 年 6 月,我们对 MEDLINE、EMBASE 和 Cochrane 图书馆进行了电子文献检索。我们纳入了连续纳入、与症状无关的女性的临床试验。
宫内粘连(IUAs)的发生率和生殖结局。
我们未发现关于米索前列醇药物治疗后 IUAs 或生殖指标的研究。我们纳入了 10 项队列研究,这些研究的方法学质量较差或一般。5 项队列研究(n = 339)报道经宫腔镜评估的女性中 IUAs 的发生率为 22.4%(95%置信区间,18.3%-27%)。与宫腔镜切除术(HR)相比,刮宫术(D&C)后 IUAs 的发生率显著更高:30% vs. 13%。分别有 29%和 1%的 D&C 和 HR 病例出现不完全排空。6 项队列研究(n = 380)报道了 D&C 和 HR 后相似的妊娠率、持续妊娠率、活产率和流产率,且 HR 后妊娠更早。但有关 IUAs 的生殖结局并未报道。
对于疑似 RPOC 的女性,HR 可能是一种更可取的手术治疗方法;与 D&C 相比,发生 IUAs 和不完全排空的情况较少,且报告的生殖结局相似。需要确认观察到的效果,并且迫切需要评估米索前列醇药物治疗和期待治疗的试验。